Pediatric and Adolescent Headache and Obesity

Part of the Headache book series (HEAD)


Childhood obesity and headaches are critical health problems that often have a marked impact on personality and social interactions that, if not addressed, can carry over into adulthood [1, 2]. The purpose of this chapter is to summarize current knowledge regarding these issues and the potential relationships between them.


  1. 1.
    Goadsby PJ, Lipton RB, Ferrari MD. Migraine – current understanding and treatment. N Engl J Med. 2002;346:257–70.CrossRefPubMedGoogle Scholar
  2. 2.
    Oakley CB, Scher AI, Recober A, Peterlin BL. Headache and obesity in the pediatric population. Curr Pain Headache Rep. 2014;18:416.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Ogden CL, Carroll MD, Flegal KM. High body mass index for age among US children and adolescents 2003–2006. JAMA. 2008;299:2401–5.CrossRefPubMedGoogle Scholar
  4. 4.
    Ng M, Fleming T, Robinson M, Thomson B, Graetz N, Margono C, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014;384:766–81.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Kroner-Herwig B, Heinrich M, Morris L. Headache in German children and adolescents: a population based epidemiological study. Cephalalgia. 2007;27:6519–27.CrossRefGoogle Scholar
  6. 6.
    Wöber-Bingöl C. Epidemiology of migraine and headache in children and adolescents. Curr Pain Headache Rep. 2013;17:341.CrossRefPubMedGoogle Scholar
  7. 7.
    Abu-Arafeh I, Razak S, Sivaraman B, Graham C. Prevalence of headache and migraine in children and adolescents: a systematic review of population-based studies. Dev Med Child Neurol. 2010;52:1088–97.CrossRefPubMedGoogle Scholar
  8. 8.
    Peterlin BL, Rosso AL, Williams MA, Rosenberg JR, Haythornthwaite JA, Merikangas KR, Gottesman RF, Bond DS, He JP, Zonderman AB. Episodic migraine and obesity and the influence of age, race, and sex. Neurology. 2013;81:1314–21.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Pinhas-Hamiel O, Frumin K, Gabis L, Mazor-Aronovich K, Modan-Moses D, Reichman B, Lerner-Geva L. Headaches in overweight children and adolescents referred to a tertiary-care center in Israel. Obesity. 2008;16:659–63.CrossRefPubMedGoogle Scholar
  10. 10.
    Hershey AD, Powers SW, Nelson TD, Kabbouche MA, Winner P, Yonker M, Linder SL, Bicknese A, Sowel MK, McClintock W, American Headache Society Pediatric Adolescent Section. Obesity in pediatric headache population: a multicenter study. Headache. 2009;49:170–7.CrossRefPubMedGoogle Scholar
  11. 11.
    Robberstad L, Dyb G, Hagen K, Stovner LJ, Holmen TL, Zwart JA. An unfavorable lifestyle and recurrent headaches among adolescents: the HUNT study. Neurology. 2010;75:712–7.CrossRefPubMedGoogle Scholar
  12. 12.
    Pakalnis A, Kring D. Chronic daily headache, medication overuse, and obesity in children and adolescents. J Child Neurol. 2012;27:577–8.CrossRefPubMedGoogle Scholar
  13. 13.
    Kinik S, Alehan F, Erol I, Kanra A. Obesity and pediatric migraine. Cephalalgia. 2010;30:105–9.CrossRefPubMedGoogle Scholar
  14. 14.
    Ravid S, Shahar E, Schiff A, Gordon S. Obesity in children with headaches: association with headache type, frequency, and disability. Headache. 2013;53:954–61.CrossRefPubMedGoogle Scholar
  15. 15.
    Lu SR, Fuh JL, Wang SJ, Juang KD, Chen SP, Liao YC, Wang YF. Incidence and risk factors of chronic daily headache in young adolescents: a school cohort study. Pediatrics. 2013;132:e9–16.CrossRefPubMedGoogle Scholar
  16. 16.
    Eidlitz-Markus T, Haimi-Cohen Y, Zeharia A. Association of pediatric obesity and migraine with comparison to tension headache and samples from othercountries. J Child Neurol. 2015;30:445–50.CrossRefPubMedGoogle Scholar
  17. 17.
    Castro K, Rockett FC, Billo M, Oliveira GT, Klein LS, Parizotti CS, Perla AS, Perry ID. Life style quality of life, nutritional status and headache in school-aged children. Nutr Hosp. 2013;28(5):1546–51.PubMedGoogle Scholar
  18. 18.
    Chai NC, Scher AI, Moghekar A, Bond DS, Peterlin BL. Obesity and headache: part I–a systematic review of the epidemiology of obesity and headache. Headache. 2014;54(2):219–34.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Peterlin BL, Rosso AL, Rapoport AM, Scher AI. Obesity and migraine: the effect of age, gender and adipose tissue distribution. Headache. 2010;50:52–62.CrossRefPubMedGoogle Scholar
  20. 20.
    Brara SM, Koebnick C, Porter AH, Langer-Gould A. Pediatric idiopathic intracranial hypertension and extreme childhood obesity. J Pediatr. 2012;161(4):602–7.CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Stiebel-Kalish H, Serov I, Sella R, Chodick G, Snir M. Childhood overweight or obesity increases the risk of IIH recurrence fivefold. Int J Obes. 2014;38(11):1475–7.CrossRefGoogle Scholar
  22. 22.
    Ravid S. Migraine and paediatric obesity: a plausible link? Indian J Med Res. 2014;139(3):343–8.PubMedPubMedCentralGoogle Scholar
  23. 23.
    Chai NC, Bond DS, Moghekar A, Scher AI, Peterlin BL. Obesity and headache: part II–potential mechanism and treatment considerations. Headache. 2014;54(3):459–71.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Coppola A, Diano S. Hormonal regulation of the arcuate nucleus melanocortin system. Front Biosci. 2007;12:3519–30.CrossRefPubMedGoogle Scholar
  25. 25.
    Denuelle M, Fabre N, Payoux P, Chollet F, Geraud G. Hypothalamic activation in spontaneous migraine attacks. Headache. 2007;47:1418–26.PubMedGoogle Scholar
  26. 26.
    Chai NC, Gelaye B, Tietjen GE, Dash PD, Gower BA, White LW, Ward TN, Scher AI, Peterlin BL. Ictal adipokines are associated with pain severity and treatment response in episodic migraine. Neurology. 2015;84(14):1409–18.CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Peterlin BL, Rapoport AM. Clinical pharmacology of the serotonin receptor agonist, zolmitriptan. Expert Opin Drug Metab Toxicol. 2007;3:899–911.CrossRefPubMedGoogle Scholar
  28. 28.
    Humphrey PP. 5-Hydroxytryptamine and the pathophysiology of migraine. J Neurol. 1991;238:S38–44.CrossRefPubMedGoogle Scholar
  29. 29.
    Goadsby PJ, Edvinsson L, Ekman R. Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular system. Ann Neurol. 1988;23:193–6.CrossRefPubMedGoogle Scholar
  30. 30.
    Zelissen PM, Koppeschaar HP, Lips CJ, Hackeng WH. Calcitonin gene-related peptide in human obesity. Peptides. 1991;12:861–3.CrossRefPubMedGoogle Scholar
  31. 31.
    Siegel JM. Hypocretin (orexin): role in normal behavior and neuropathology. Annu Rev Psychol. 2004;55:125–48.CrossRefPubMedGoogle Scholar
  32. 32.
    Holland PR, Akerman S, Goadsby PJ. Orexin 1 receptor activation attenuates neurogenic dural vasodilation in an animal model of trigeminovascular nociception. J Pharmacol Exp Ther. 2005;315:1380–5.CrossRefPubMedGoogle Scholar
  33. 33.
    Sarchielli P, Alberti A, Baldi A, Coppola F, Rossi C, Pierguidi L, et al. Proinflammatory cytokines, adhesion molecules, and lymphocyte integrin expression in the internal jugular blood of migraine patients without aura assessed ictally. Headache. 2006;46:200–7.CrossRefPubMedGoogle Scholar
  34. 34.
    Rozen T, Swidan SZ. Elevation of CSF tumor necrosis factor alpha levels in new daily persistent headache and treatment refractory chronic migraine. Headache. 2007;47:1050–5.CrossRefPubMedGoogle Scholar
  35. 35.
    Matsubara M, Maruoka S, Katayose S. Inverse relationship between plasma adiponectin and leptin concentrations in normal-weight and obese women. Eur J Endocrinol. 2002;147:173–80.CrossRefPubMedGoogle Scholar
  36. 36.
    Kitamura E, Kanazawa N, Hamada J. Hyperleptinemia increases the susceptibility of the cortex to generate cortical spreading depression. Cephalalgia. 2015;35:327–34.CrossRefPubMedGoogle Scholar
  37. 37.
    Guldiken B, Guldiken S, Demir M, Turgut N, Tugrul A. Low leptin levels in migraine: a case controlstudy. Headache. 2008;48(7):1103.CrossRefPubMedGoogle Scholar
  38. 38.
    Ligong Z, Jinjin Q, Chunfu C, Congcong L, Xiaojun D. Effect of obesity and leptin level on migraineurs. Med Sci Monit. 2015;21:3270–4.CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    Haque B, Rahman KM, Hoque A, Hasan AT, Chowdhury RN, Khan SU, et al. Precipitating and relieving factors of migraine vs tension type headache. BMC Neurol. 2012;12:82.CrossRefPubMedPubMedCentralGoogle Scholar
  40. 40.
    Overath CH, Darabaneanu S, Evers MC. Does an aerobic endurance programme have an influence on information processing in migraineurs? J Headache Pain. 2014;15:11.CrossRefPubMedPubMedCentralGoogle Scholar
  41. 41.
    Milde-Busch A, Blaschek A, Borggräfe I, Heinen F, Straube A, von Kries R. Associations of diet and lifestyle with headache in high-school students: results from a cross-sectional study. Headache. 2010;50:1104–14.CrossRefPubMedGoogle Scholar
  42. 42.
    Bonfert M, Straube A, Schroeder AS, Reilich P, Ebinger F, Heinen F. Primary headache in children and adolescents: update on pharmacotherapy of migraine and tension-type headache. Neuropediatrics. 2013;44:3–19.CrossRefPubMedGoogle Scholar
  43. 43.
    Verrotti A, Agostinelli S, D’Egidio C, Di Fonzo A, Carotenuto M, Parisi P. Impact of a weight loss program on migraine in obese adolescents. Eur J Neurol. 2013;20:394–7.CrossRefPubMedGoogle Scholar
  44. 44.
    Egger J, Carter CM, Soothill JF, Wilson J. Oligoantigenic diet treatment of children with epilepsy and migraine. J Pediatr. 1989;114:51–8.CrossRefPubMedGoogle Scholar
  45. 45.
    Egger J, Carter CM, Wilson J, Turner MW, Soothill JF. Is migraine food allergy? A double-blind controlled trial of oligoantigenic diet treatment. Lancet. 1983;2:865–9.CrossRefPubMedGoogle Scholar
  46. 46.
    Marcus DA, Scharff L, Turk D, Gourley LM. A double-blind provocative study of chocolate as a trigger of headache. Cephalalgia. 1997;17:855–62.CrossRefPubMedGoogle Scholar
  47. 47.
    Kossoff EH, Huffman J, Turner Z, Gladstein J. Use of the modified Atkins diet for adolescents with chronic daily headache. Cephalalgia. 2010;30:1014–6.PubMedGoogle Scholar
  48. 48.
    Bond DS, Vithiananthan S, Nash JM, Thomas JG, Wing RR. Improvement of migraine headachesin severely obese patients after bariatric surgery. Neurology. 2011;76:1135–8.CrossRefPubMedPubMedCentralGoogle Scholar
  49. 49.
    Novack V, Fuchs L, Lantsberg L, et al. Changes in headache frequency in premenopausal obese women with migraine after bariatric surgery: a case series. Cephalalgia. 2011;31:1336–42.CrossRefPubMedGoogle Scholar
  50. 50.
    Gunay Y, Jamal M, Capper A, et al. Rouxen-Y gastric bypass achieves substantial resolution of migraine headache in the severely obese: 9-year experience in 81 patients. Surg Obes Relat Dis. 2013;9:55–62.CrossRefPubMedGoogle Scholar
  51. 51.
    Ells LJ, Mead E, Atkinson G, Corpeleijn E, Roberts K, Viner R, Baur L, Metzendorf MI, Richter B. Surgery for the treatment of obesity in children and adolescents. Cochrane Database Syst Rev. 2015;(6):CD011740.Google Scholar
  52. 52.
    Kowacs PA, Piovesan EJ, Tepper SJ. Rejection and acceptance of possible side effects of migraine prophylactic drugs. Headache. 2009;49(7):1022.CrossRefPubMedGoogle Scholar
  53. 53.
    Verotti A, Parisi P, Agostinelli S, Loiacono G, Marra F, Coppola G, et al. Weight regain after discontinuation of topiramate treatment in patients with migraine: a prospective observational study. CNS Drugs. 2015;29:163–9.CrossRefGoogle Scholar
  54. 54.
    Cervoni C, Bond DS, Seng EK. Behavioral weight loss treatments for individuals with migraine and obesity. Curr Pain Headache Rep. 2016;20:13.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG 2017

Authors and Affiliations

  1. 1.Pediatric Headache Clinic, Day Hospitalization DepartmentSchneider Children’s Medical Center of IsraelPetach TikvaIsrael
  2. 2.Sackler Faculty of MedicineTel Aviv UniversityTel AvivIsrael
  3. 3.Juvenile Headache Centre, Department of Woman’s and Child’s HealthUniversity Hospital of PaduaPaduaItaly

Personalised recommendations